Bcl-2-IN-4 is a potent, orally active and selective Bcl-2 inhibitor with an IC 50 of 1.5 nM. Bcl-2-IN-4 displays >200-fold selectivity over Bcl-xL (IC 50 of 411 nM). Bcl-2-IN-4 inhibits RS4; 11 cell proliferation with an IC 50 of 2.7 nM (WO2021180040A1; compound 2).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bcl-2 Family
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.